Vizuri Health Sciences LLC Granted New US Patent for Novel Topical Analgesic Formulations Containing

FAIRFAX, Va.--(BUSINESS WIRE)--Jul 16, 2018--Vizuri Health Sciences LLC, a pharmaceutical and over-the-counter (OTC) product development company, today announced the issuance of a U.S. patent that further protects its capsaicin-based product pipeline. Newly issued U.S. Patent 9,956,190, titled “Topical Compositions for Pain Relief, Manufacture and Use,” grants Vizuri exclusive rights to certain high strength topical capsaicin compositions. The patent enhances the protection of the company’s established PainBloc24 ® OTC capsaicin product as well as the company’s prescription-strength capsaicin formulation products CGS-200-1 (1% capsaicin) and CGS-200-5 (5% capsaicin) that are currently being evaluated in a Phase 2 clinical study for the relief of osteoarthritic knee pain.

source:

https://www.thedailytimes.com/business/vizuri-health-sciences-llc-granted-new-us-patent-for-novel/article_59c86c3f-f4ea-544d-988d-a5328e616104.html